Skip to Main Content

Advanced Search

Customer Connect Login | Payer Login | Surveyor Login

CARF Canada | CARF-CCAC | uSPEQ®

  • Opioid Treatment Program

    Opioid treatment programs provide rehabilitation and medical support for persons addicted to opioid drugs. The duration of treatment should be based on the needs of the persons served and should take into consideration the benefit of medication-assisted treatment. The medications used to achieve treatment goals include methadone and buprenorphine, which are approved by the Food and Drug Administration (FDA) for the use in the treatment of opioid dependence.

    Services are directed at reducing or eliminating the use of illicit drugs, criminal activity, and/or the spread of infectious disease while improving the quality of life and functioning of the persons served. Opioid treatment programs follow rehabilitation stages of sufficient duration to meet the needs of persons served.

    In November 2001, the Substance Abuse and Mental Health Services Administration (SAMHSA) announced that CARF was an approved accreditation provider for opioid treatment programs providing outpatient, residential, and detoxification services in the United States.

    SAMHSA's approval of CARF accreditation is part of the federal government's 42 CFR, Part 8, which shifts regulatory oversight from the FDA to a national accreditation model under SAMHSA/Center for Substance Abuse Treatment (CSAT) oversight.

    Please refer to the program descriptionsNew window icon for further details.

    For more information on CARF opioid treatment program accreditation, please email otp@carf.org or call toll free (888) 281-6531.

  • Share
  • Email
  • Print
  • RSS

Text: A A A

  • A couple embraces affectionately

Legal notices  Contact Us